Nicotinamide adenine dinucleotide — the cellular repair coenzyme that declines with age. Replenished via IV for longevity and cognitive support.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every cell that drives energy production, DNA repair, and cellular regeneration. NAD+ levels decline by approximately 50% between ages 40 and 60 — contributing to fatigue, cognitive decline, and accelerated ageing. IV NAD+ therapy replenishes cellular stores at concentrations not achievable through oral precursors, supporting the sirtuins and PARP enzymes responsible for DNA repair and longevity signalling.
IV NAD+ bypasses the rate-limiting conversion steps required by oral precursors (NMN, NR). It enters cells via the Preiss-Handler pathway and is immediately available for mitochondrial respiration and nuclear DNA repair. Sessions are administered slowly (2–4 hours) to manage the mild flushing and chest pressure that can occur with faster infusion rates.
No downtime. Mild flushing, warmth, and occasional nausea during infusion are normal and managed by slowing the drip rate. Most clients work, read, or rest during the session. Effects are cumulative — benefits deepen with each session.
“The longevity programme changed how I think about my health. My doctor built a plan around my actual results, not a generic protocol.”
“I come in monthly now. The energy boost is noticeable and my biomarkers have steadily improved. It fits into my routine with zero hassle.”
“Finally a clinic that took my symptoms seriously. The testing was thorough and the protocol made a real difference within the first month.”